Lam B, Younossi ZM. Review: treatment options for nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology . 2010; 3 (2):121–137.Lam B, Younossi ZM. Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2010; 3 :121–137....
"Currently there are no treatment options for NASH to prevent progression of liver disease, other than patient education and lifestyle changes," Ms Goonetilleke said. "That means alternative options need to be explored, so we hope the findings from this study will lead to the development of e...
Gallstone disease. Pathophysiology, epidemiology, natural history, and treatment options. In 1991, only symptomatic gallstones should be treated. The treatment of choice for all gallstones continues to be surgical removal. Except for stones in t... John C. Bowen,Howard I. Brenner,WA Ferrante,....
We hope that soon we will be having an effective multi-therapeutic regimen for each disease. Key words: Alcoholic liver disease; non-alcoholic fatty WJG|www.wjgnet.com 6549 September 28, 2017|Volume 23|Issue 36| Singh S et al . Treatment options for ALD and NAFLD ...
There are currently three treatment options for liver hydatidosis: urgery, which remains the mainstay of radical treatment; ultrasound-guided aspiration (puncture/aspiration/injection/reaspiration--PAIR); and chemotherapy with benzimidazole compounds (albendazole and mebendazole). Chemotherapy is a noninvasi...
We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections. J Infect Chemother, 2024, 30(7): 621-625. 37. Petrosillo N, Taglietti F, Granata G. Treatment options for colistin resistant Klebsiella pneumoniae: present and future. J Clin Med,...
Curativetreatmentoptions for early-stage hepatocellular carcinoma (HCC), the most common type of liver cancer, include surgery, liver transplantation andradiofrequency ablation. However, manypatientsare not candidates for these therapies due to the presence of other conditions. In addition, these treatme...
developing liver disease due to medications such as niacin. Recent studies have found that niacin may not be as effective as previously thought in controlling high cholesterol. Patients who take niacin may want to see their health care professional to determine if other treatment options may be ...
While no cure is yet available for Fabry disease, a rare genetic disorder, there are several treatment options that can help ease Fabry disease symptoms. Treatment can slow the progression of organ damage, improve quality of life, and prolong Fabry disease life expectancy for affected patients....